Editorial
 DRUG BAN POLICY   
 Wednesday, December 04, 2013 
 A leading financial daily reported last week that the Union health ministry is considering to disallow marketing of drugs in India which are already banned in two or more countries on grounds of efficacy and safety. 
  Past Editorial...  
TODAY'S NEWS
18:10  [IST]Celon Labs enters JV with Aurobindo to develop hormonal & oncology generic formulations
18:00  [IST]Phase III data confirm long-lasting characteristics of Alprolix and Eloctate across multiple hemophilia populations
17:45  [IST]Wipro wins national award for empowerment of persons with disabilities
17:30  [IST]ASI moots use of PEP to safeguard victims of sexual assault against HIV
17:10  [IST]Lilly enters branded generics market with launch of four new cancer drugs
17:00  [IST]The Caisse des Depots, Sanofi sign an pact to help with Biocitech’s development
more news >>
TOP NEWS
08:00  [IST]An innovative Indian R&D proposal may get WHO funding for development
08:00  [IST]Dept of Ayush gives one year time to implement sub-rule (1B) & (1C) in Rule 157 of D&C Act
08:00  [IST]IPA asks PCI to make B. Pharm as minimum qualification for registration as pharmacist
08:00  [IST]Baring India sees geographical diversification driven by patent expires, rise in R&D spend as 2 emerging trends
08:00  [IST]Regulatory officials in Gurgaon seize habit forming drugs worth Rs.one lakh from an unlicensed godown
08:00  [IST]Experts for inclusion of a South African model REC in CDA Bill for continuous monitoring of ECs
more news >>
YESTERDAY'S NEWS
18:00  [IST]EMA's PRA committee considers benefits of Kogenate Bayer/Helixate NexGen outweigh risks in previously untreated patients
17:25  [IST]Venus Remedies signs MoU with Austell Laboratories to out-license Elores in South Africa
17:15  [IST]Wockhardt introduces E-learning programme in Aurangabad
17:00  [IST]Genocea begins phase I study of vaccine candidate GEN-004 to prevent infections caused by pneumococcus
16:45  [IST]GE unveils its first lifesciences solution ‘AKTA start’ developed in India to automate protein purification
16:00  [IST]Novartis highlights research on investigational, personalized T cell therapy CTL019 in patients with forms of acute and chronic leukemia
more news >>
INTERVIEW  
South America an important market for Indian bio-pharma in future
Ajay Bharadwaj.jpgAjay Bharadwaj, CEO, Anthem Biosciences
Past Interviews...
 
  What's New?  
 
Opinion Poll
 
 
Will the newly introduced audio-visual recording of informed consent bring the much needed transparency in clinical trials in India?
  
 
 
 

   
 
 
  Corporate
Pharma Stocks
Executive Diary
Pharma People
Product Launches
  Special Features
Features
  Chronicle Pharmabiz Specials
Forthcoming
  Past
 
  Forthcoming Events
International
  Domestic
 
TENDERS & PROJECTS
Tenders & Enquiries
Pharma Projects
CORPORATE
Company Profile
Corporate Results
Corporate X-ray
Pharmabiz Studies of Top Companies
US FDA UPDATE
US FDA: ANDA
US FDA: Warnings
US FDA: Approved NMEs
US FDA: New Approvals
US FDA: REFUSAL
EXPORT & IMPORT
Drug Export Procedures
Drug Units With WHO GMP Certification
Pharma Export Data
Import Reg. Update
PHARMA LAWS & DOCUMENTS
Notifications
Pharma Regulations
Patent Laws and Amendments
Patent Scan
Documents
New Drug Approvals
Notified Prices
LIST OF LABS & GOVT. BODIES
Govt Recognised In-House R&D Units
AICTE Boards & Committees
List of Indian CROs
List of CROs (International)
Govt & approved labs of India
List of State Drugs Controllers
 
 
 
 
 
 
Copyright © 2010 Saffron Media Pvt. Ltd |